-+ 0.00%
-+ 0.00%
-+ 0.00%

Medipal names Kuniaki Imagawa president, CEO effective Oct. 1

PUBT·09/08/2026 06:31:58
Listen to the news
Medipal names Kuniaki Imagawa president, CEO effective Oct. 1
  • Medipal set a management reshuffle effective Oct. 1, 2026, naming Kuniaki Imagawa as representative director, president and CEO.
  • Imagawa has led Mediceo as representative director, president and CEO since April 2022, following senior roles in sales strategy, business development.
  • Shuichi Watanabe will move from president and CEO to representative director, chairman, retaining chief compliance officer responsibilities.
  • Yasuhiro Choufuku will serve as representative director, vice president in charge of the pharmaceutical business; acting president duties end Sept. 30.
  • Director Hiroshi Yarimizu will continue overseeing financial strategy; external post at ATOL will end while Toshichi audit role remains.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medipal Holdings Corporation published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.